Guided by Experts, Driven by Mission
Our board brings together leaders in medicine, law, and public health. Together, they guide our advocacy and research to ensure psychedelic policy is ethical, evidence-based, and centered on the public interest.
Board of Directors
Our board brings together experts in clinical research, health law, and social equity to guide the future of psychedelic policy with integrity and pragmatism.
Dr. Elena Vance
Board Chair & Senior Researcher
Marcus Thorne
Elena is a neuropharmacologist specializing in clinical policy frameworks. Her work focuses on bridging the gap between scientific breakthroughs and scalable public healthcare integration.
Policy Strategy Director
Sarah Jenkins
With a background in state health regulatory affairs, Marcus manages our legislative advocacy efforts. He focuses on creating evidence-based reforms that protect public interests and patient safety.
Equity & Access Lead
Sarah specializes in ensuring policy initiatives remain centered on equitable access for underserved populations. She brings lived experience and community-based advocacy to our regulatory frameworks.